Antiarrhythmics After Ablation of Atrial Fibrillation (5A Study) | Zendy

Jean-François Roux | Zendy; Erica S. Zado | Zendy; David J. Callans | Zendy; Fermin C. García | Zendy; David Lin | Zendy; Francis E. Marchlinski | Zendy; Rupa Bala | Zendy; Sanjay Dixit | Zendy; Malcolm Riley | Zendy; Andrea M. Russo | Zendy; Mathew D. Hutchinson | Zendy; Joshua M. Cooper | Zendy; Ralph J. Verdino | Zendy; Vickas Patel | Zendy; Parijat S. Joy | Zendy; Edward P. Gerstenfeld | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Antiarrhythmics After Ablation of Atrial Fibrillation (5A Study)

Author(s) -

Jean-François Roux,

Erica S. Zado,

David J. Callans,

Fermin C. García,

David Lin,

Francis E. Marchlinski,

Rupa Bala,

Sanjay Dixit,

Malcolm Riley,

Andrea M. Russo,

Mathew D. Hutchinson,

Joshua M. Cooper,

Ralph J. Verdino,

Vickas Patel,

Parijat S. Joy,

Edward P. Gerstenfeld

Publication year - 2009

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/circulationaha.108.839639

Subject(s) - medicine , atrial fibrillation , ablation , cardioversion , cardiology , clinical endpoint , anesthesia , incidence (geometry) , randomized controlled trial , physics , optics

Atrial arrhythmias are common early after atrial fibrillation (AF) ablation. We hypothesized that empirical antiarrhythmic drug (AAD) therapy for 6 weeks after AF ablation would reduce the occurrence of atrial arrhythmias.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research